Laboratoire Chimie Electrochimie Moléculaires et Chimie Analytique

The performance of hybrid organic perovskite (HOP) for solar energy conversion is driving a renewed interest in their light emitting properties. The recent observation of broad visible emission in layered HOP highlights their potential as white-light emitters. Improvement of the efficiency of the material requires a better understanding of its photophysical properties. We present in-depth experimental investigations of white-light (WL) emission in thin films of the (C6H11NH3)2PbBr4. The broadband, strongly Stokes shifted emission presents a maximum at 90 K when excited at 3.815 eV, and below this temperature coexists with an excitonic edge emission. X-rays and calorimetry measurements exclude the existence of a phase transition as an origin of the thermal behavior of the WL luminescence. The free excitonic emission quenches at low temperature, despite a binding energy estimated to 280 meV. Time-resolved photoluminescence spectroscopy reveals the multicomponent nature of the broad emission. We analyzed the dependence of these components as a function of temperature and excitation energy. The results are consistent with the existence of self-trapped states. The quenching of the free exciton and the thermal evolution of the WL luminescence decay time are explained by the existence of an energy barrier against self-trapping, estimated to ∼10 meV.

Abstract Despite multiple research approaches to prevent bacterial colonization on surfaces, device‐associated infections are currently responsible for about 50% of nosocomial infections in Europe and significantly increase health care costs, which demands development of advanced antibacterial surface coatings. Here, novel antimicrobial composite materials incorporating zinc oxide nanoparticles (ZnO NP) into biocompatible poly( N ‐isopropylacrylamide) (PNIPAAm) hydrogel layers are prepared by mixing the PNIPAAm prepolymer with ZnO NP, followed by spin‐coating and photocrosslinking. Scanning electron microscopy (SEM) characterization of the composite film morphology reveals a homogeneous distribution of the ZnO NP throughout the film for every applied NP/polymer ratio. The optical properties of the embedded NP are not affected by the matrix as confirmed by UV‐vis spectroscopy. The nanocomposite films exhibit bactericidal behavior towards Escherichia coli (E. coli) for a ZnO concentration as low as ≈0.74 μg cm −2 (1.33 mmol cm −3 ), which is determined by inductively coupled plasma optical emission spectrometry. In contrast, the coatings are found to be non‐cytotoxic towards a mammalian cell line (NIH/3T3) at bactericidal loadings of ZnO over an extended period of seven days. The differential toxicity of the ZnO/hydrogel nanocomposite thin films between bacterial and cellular species qualifies them as promising candidates for novel biomedical device coatings.

Treatment of [Fe2(mu-pdt)(CO)6] [pdt=S(CH2)3S] with dppe (Ph2PCH2CH2PPh2) in refluxing toluene affords the asymmetric complex [Fe2(mu-pdt)(CO)4(dppe)] (1). Protonation of 1 with HBF4-Et2O in CH2Cl2 gives at room temperature the mu-hydrido derivative [Fe2(mu-pdt)(CO)4(dppe)(mu-H)](BF4) (2). Monitoring the reaction by 1H, 31P, and 13C NMR at low temperature reveals unambiguously that the process of the protonation of 1 implies terminal hydride intermediates.

The silver-based MOF material Ag3(3-phosphonobenzoate) was evaluated as a bactericidal material. A sustainable release of Ag+, which was quantified by cathodic stripping voltammetry, was responsible for bactericidal activity against the 6 bacterial strains tested.

Gene PRAME was found to encode an antigen recognized on a human melanoma cell line by an autologous cytolytic T-lymphocyte clone. This gene is expressed at a high level in a very large fraction of tumours, such as melanomas, non-small-cell lung carcinomas, sarcomas, head and neck tumours and renal carcinomas. It is therefore a candidate for tumour immunotherapy even though some low expression is found in certain normal tissues. We tested by RT-PCR the expression of PRAME on more than 250 bone marrow or blood samples from patients with a haematological malignancy. Approximately 25% of the acute leukaemia samples were positive. Remarkably, all acute myeloblastic leukaemias that carried the chromosomal translocation t(8;21), which fuses the genes AML1 and ETO, expressed PRAME at a high level.

The phosphonic acid functional group, which is characterized by a phosphorus atom bonded to three oxygen atoms (two hydroxy groups and one P=O double bond) and one carbon atom, is employed for many applications due to its structural analogy with the phosphate moiety or to its coordination or supramolecular properties. Phosphonic acids were used for their bioactive properties (drug, pro-drug), for bone targeting, for the design of supramolecular or hybrid materials, for the functionalization of surfaces, for analytical purposes, for medical imaging or as phosphoantigen. These applications are covering a large panel of research fields including chemistry, biology and physics thus making the synthesis of phosphonic acids a determinant question for numerous research projects. This review gives, first, an overview of the different fields of application of phosphonic acids that are illustrated with studies mainly selected over the last 20 years. Further, this review reports the different methods that can be used for the synthesis of phosphonic acids from dialkyl or diaryl phosphonate, from dichlorophosphine or dichlorophosphine oxide, from phosphonodiamide, or by oxidation of phosphinic acid. Direct methods that make use of phosphorous acid (H 3 PO 3 ) and that produce a phosphonic acid functional group simultaneously to the formation of the P–C bond, are also surveyed. Among all these methods, the dealkylation of dialkyl phosphonates under either acidic conditions (HCl) or using the McKenna procedure (a two-step reaction that makes use of bromotrimethylsilane followed by methanolysis) constitute the best methods to prepare phosphonic acids.

The capacity for the brain to produce acetaldehyde (AcHO) from ethanol was determined in rat brain homogenates. Rat brains were perfused with saline-heparin solution and homogenized in a phosphate buffer. Varying amounts of tissue were incubated with ethanol (0-100 mM) for periods of up to 60 min. The reaction was stopped by the addition of desferrioxamine and ice-cold perchloric acid. Supernatants were treated with dinitrophenylhydrazine reagent, extracted with isooctane in the presence of an internal standard, and the derivatives were separated by HPLC. The addition of 4-methyl pyrazole (an alcohol dehydrogenase inhibitor) or metyrapone (a cytochrome P450 inhibitor) had no effect on the amount of recovered AcHO. On the other hand, treatment with the catalase inhibitors sodium azide, cyanamide, or 3-amino-1,2,4-triazole blocked the production of AcHO while the addition of exogenous peroxide or a peroxide-generating system enhanced the production of AcHO. Overall, these results suggest that AcHO may be produced in the brain during alcohol intoxication, through the action of the enzyme catalase.

The purpose of this investigation was to assess the effect of chlormethiazole treatment on liver damage in the experimental rat intragastric ethanol-feeding model of alcoholic liver disease. Chlormethiazole has been used in the treatment of alcoholic withdrawal and has been shown to inhibit cytochrome P4502E1. Since treatment of experimental alcoholic liver disease with CYP2E1 inhibitors had an ameliorating effect on liver injury in the rat, chlormethiazole was used to see if it had a similar effect. Rats fed ethanol for 2 months had significantly less liver injury when chlormethiazole was added to the diet, fed intragastrically. The CYP2E1 apoprotein levels, which were increased by ethanol feeding, were also increased when chlormethiazole was fed with ethanol. Chlormethiazole inhibited the increase in the ethanol-induced CYP2E1 activity in vivo, as measured by chlorzoxazone 6-hydroxylation, but did not affect the level of CYP2E1 apoprotein. Likewise, the reduction in proteasome proteolytic enzyme activity produced by ethanol feeding was blunted in chlormethiazole-fed rats. These results support the conclusion that chlormethiazole treatment partially protects the liver from injury by inhibiting CYP2E1 activity in vivo.

Studies of the protonation of [Fe2(CO)4(kappa2-PNP)(mu-pdt)] (1; PNP = (Ph2PCH2)2NCH3) by HBF4.Et2O showed that the nature of the reaction product depends on whether the reaction is conducted in acetone or in dichloromethane. In acetone, an N-protonated form, 2, is isolated. Tautomerization of 2 in CH2Cl2 gives rise to a mu-hydride species 3. Variable-temperature NMR experiments have been performed to clarify the processes involved.

The reaction of [Fe2(μ-S(CH2)3S)(CO)6] with an excess of 1,3-dimethylimidazol-2-ylidene (LMe) affords the mono- and disubstituted species [Fe2(μ-S(CH2)3S)(CO)5(LMe)] (1) and [Fe2(μ-S(CH2)3S)(CO)4(LMe)2] (2), respectively. The structures of 1 and 2 have been determined by X-ray crystallography.

Susceptibility to cancer or ethanol-related liver diseases may be associated with a large variability in cytochrome P450 2E1 activity. This variability may be of genetic origin or reflect environmental factors. To test the role of genetics, the phenotype and genotype of this enzyme were determined in 42 non-alcoholic and 74 alcoholic patients hospitalized for detoxification treatment. Chlorzoxazone metabolism was used to assess CYP2E1 phenotype. Restriction length fragment polymorphisms with Rsa I or Pst I, and Dra I endonucleases were used to determine the two mutant alleles, Pst I/Rsa I-c2 and Dra I-C. A significant gender difference in basal CYP2E1 activity was observed in non-smoking controls (p < 0.05) but not in alcoholics or smokers. Subjects heterozygous for the C or c2 mutated allele did not show any difference in CYP2E1 activity at the basal level, compared with the wild type homozygotes. Conversely, patients with the mutated genotype appeared less inducible than the others after ethanol induction (p < 0.01).

In this paper we shall discuss the concept of method validation, describe the various elements and explain its close relationship with fitness for purpose. Method validation is based on the assumption that a series of requirements are fulfilled and we shall explain how these requirements are selected, the way in which evidence is supplied and what work has to be carried out in the laboratory. The basic principles of method validation and the different ways to validate a methodology, by inter-laboratory comparison or performing an in-house validation, are also described.

Reaction of [Fe2{μ-S(CH2)3S}(CO)6] (1) at room temperature with the N-heterocyclic carbenes IMe-(CH2)2-L (IMe = 1-methylimidazol-2-ylidene, L = NMe2, SMe) afforded the pentacarbonyl carbene derivatives [Fe2{μ-S(CH2)3S}(CO)5{IMe-(CH2)2-NMe2}] (2a) and [Fe2{μ-S(CH2)3S}(CO)5{IMe-(CH2)2-SMe}] (2b). Reaction of 1 with IMe-CH2-IMe at room temperature provided the dimer [{Fe2(μ-S(CH2)3S)(CO)5}2{μ-(IMe-CH2-IMe)}] (3) together with the chelated bis-NHC complex [Fe2{μ-S(CH2)3S}(CO)4{IMe-CH2-IMe}] (4a) as the major product. The analogous reaction of 1 with IMe-(CH2)2-IMe yielded the chelated bis-NHC complex [Fe2(μ-S(CH2)3S)(CO)4{IMe-(CH2)2-IMe}] (4b). Addition of HBF4 to compound 4a afforded the stable bridging hydride complexes [Fe2(μ-H){μ-S(CH2)3S}(CO)4{IMe-CH2-IMe}](BF4) (5a,b) with NHC ligands in a basal/basal and basal/apical mode of coordination in 5a,b, respectively. The molecular structures of 2a, 3, 4a,b, and 5a were confirmed by X-ray diffraction studies. Low-temperature NMR studies on the protonation of 4a showed spectroscopic evidence for the formation of a very unstable terminal hydride and a bridging hydride species with a NHC ligand having a non classical mode of coordination via a C-4(5) bond. Cyclic voltammetry revealed that 4a is a catalyst for proton reduction.

CYP2E1 is involved in the activation of various carcinogens, including N-nitrosamines, which are believed to be important in human carcinogenesis. Humans exhibit wide interindividual variability in levels of CYP2E1 mRNA and protein, which might explain interindividual differences in susceptibility to carcinogens activated by CYP2E1. Such variability could be due either to genetic polymorphisms observed in the CYP2E1 gene (Rsa I in the 5'-flanking region, Dra I in intron 6 and Taq I in intron 7) or to varying inducibility by xenobiotics. The aim of the present study was to establish whether, in a Caucasian population (n = 93), there existed a relationship between allelic forms of the CYP2E1 gene and the phenotype determined in vitro by hepatic ability to 6-hydroxylate chlorzoxazone. Rates of chlorzoxazone-6-hydroxylation were significantly correlated with levels of immunochemically measured CYP2E1 (p < 0.001). CYP1A2, 2C8, 2C9, 2C18, 2D6, 3A4 and 3A5 did not appear to be significantly involved in chlorzoxazone metabolism, whereas the participation of CYP1A1 could not be excluded. Frequencies of the rare alleles for the three polymorphism sites were 2.2% for RsaI, 7.5% for DraI and 8.5% for TaqI. Despite substantial interindividual variations in chlorzoxazone hydroxylase activity, no relationship between any of the three polymorphisms and CYP2E1 activity was established. Therefore, in humans, interindividual variability in CYP2E1 levels is probably due to differing induction levels as a result of environmental factors, or to genetic factors other than those studied in this work.

We report a two-dimensional Hofmann-like spin-crossover (SCO) material, [Fe(trz-py)2{Pt(CN)4}]·3H2O, built from [FePt(CN)4] layers separated by interdigitated 4-(2-pyridyl)-1,2,4,4H-triazole (trz-py) ligands with two symmetrically inequivalent FeII sites. This compound exhibits an incomplete first-order spin transition at 153 K between fully high-spin (HS–HS) and intermediate high-spin low-spin (HS–LS) ordered states. At low temperature, it undergoes a bidirectional photoswitching to HS–HS and fully low-spin (LS–LS) states with green and near-IR light irradiation, respectively, with associated T(LIESST = Light-Induced Excited Spin-State Trapping) and T(reverse-LIESST) values of 52 and 85 K, respectively. Photomagnetic investigations show that the reverse-LIESST process, performed from either HS-HS or HS-LS states, enables access to a hidden stable LS-LS state, revealing the existence of a hidden thermal hysteresis. Crystallographic investigations allowed to identify that the strong metastability of the HS-LS state originates from the existence of a strong elastic frustration causing antiferroelastic interactions within the [FePt(CN)4] layers, through the rigid NC-Pt-CN bridges connecting the inequivalent FeII sites. The existence of the stable LS-LS state paves the way for a multidirectional photoswitching and allows potential applications for electronic devices based on ternary digits.

Over the last several years, various gene delivery systems have been developed for gene therapy applications. Although viral vector-based gene therapy has led to the greatest achievements in animal and human studies, synthetic non-viral vectors have also been developed as they offer several advantages over viral systems, including lower immunogenicity and greater nucleic acid packaging capacity. Nevertheless, the transfection efficiency of the current non-viral gene carriers still needs to be improved, especially as regards direct in vivo transfection. In particular, cationic lipid/nucleic acid complexes (termed lipoplexes) have been the subject of intensive investigation with a view to optimize their performance and to better understand their mechanisms of action, and consequently to design new approaches to overcome the critical barriers of cationic liposome-mediated gene delivery. A possible strategy may rely on considering the membrane constituents and properties of the vast variety of living organisms as a source of inspiration for the design of biocompatible, non-toxic and effective novel artificial liposomal systems. Thus, the present forward-looking review provides an overview of the progress already made during the last years in the field of cationic lipid-mediated gene transfection and also focuses on a series of novel bio-inspired lipids for both in vitro and in vivo gene transfection.

Ritonavir, indinavir, and saquinavir, all human immunodeficiency virus-1 protease inhibitors with a potent antiviral effect during triple therapy, are extensively metabolized by liver cytochrome P450 3A4. As this P450 isoform is involved in the metabolism of about 50% of drugs, coadministration of protease inhibitors with other drugs may lead to serious effects due to enzyme inhibition. Among these drugs, methadone and buprenorphine, both metabolized by P450 3A4, are potential candidates to drug interactions. In this study, metabolic interactions between these protease inhibitors and methadone or buprenorphine were studied in vitro in a panel of 13 human liver microsomes. Ritonavir was the most potent competitive inhibitor with Ki about 50 and 20 nM for methadone and buprenorphine metabolisms, respectively. Indinavir and saquinavir also inhibited methadone N-demethylation (Ki about 3 and 15 microM, respectively) and buprenorphine N-dealkylation (Ki about 0.8 and 7 microM, respectively). The rank order of inhibition potency against metabolism of methadone and buprenorphine was ritonavir > indinavir > saquinavir. There is obvious potential for clinically significant drug interactions, particularly with ritonavir. In brief, caution should be advised if human immunodeficiency virus-1 protease inhibitors are coadministered with methadone and buprenorphine.

We present a new example of a mononuclear iron(ii) complex exhibiting a correlated spin-crossover (SCO) transition and strong fluorescence, whose coordination sphere is saturated, for the first time, by six phosphorescent ligands. The interplay between SCO and light emission properties in the thermal region of the spin transition was investigated by means of magnetic, fluorescence, optical absorption and optical microscopy measurements on a single crystal. Overall, the results show an excellent correlation between fluorescence and magnetic data of the present gradual transition, indicating an extreme sensitivity of the optical activity of the ligand to the spin state of the active iron(ii) ions. These results open the way for conceiving new prototypes of pressure and temperature sensors based on this synergy between SCO and luminescence properties. In particular, the fact that cooperative SCO material is not a prerequisite for obtaining such synergetic effects, is useful for the design of thin films or nanoparticles, in which the cooperativity is reduced, for appropriate implementation in nanosized devices to enhance the sensing properties at the nanoscale.

Organic–inorganic hybrid perovskites (OIHP) are developing rapidly as high-performance semiconductors for solid-state solar cells and light emitting devices. Recently, lead-halide two-dimensional (2D) OIHP were found to present bright broadband visible emission, thus, highlighting their potential as single component white-light (WL) emitters. This contribution deals with the preparation of a new Cd-based 2D hybrid perovskite, of the chemical formula (C6H11NH3)2CdBr4 (abbreviated as compound 1), of which structural and optical properties have been studied and analyzed. Room temperature optical absorption (OA) measurements, performed on spin-coated film of compound 1, revealed a sharp excitonic absorption peak at 3.24 eV, and a large exciton binding energy of 377 meV, estimated from low temperature OA spectrum. Upon 325 nm irradiation, compound 1 showed a very broadband WL emission consisting of one peak at 2.94 eV, attributed to exciton confined in the [CdBr4]2– inorganic layers, and a second peak at 2.53 eV resulting from the cyclohexylammonium cations emission. Temperature dependence of PL spectra evidenced anomalous behavior accompanied by singularities around 50 and 150 K in the integrated intensity, the full width at half-maximum and the PL peaks positions. These singularities have been traced back to structural phase transitions, from temperature dependence powder and single crystal X-ray diffraction investigations, from which strong correlations had emerged between the structural distortion of the CdBr6 pseudo-octahedron and the broadening characteristics of the WL emission band. These hitherto unrecognized properties turn this and similar OIHP into perspective candidates for potential applications as WL-emitting diodes.

A cavity that acts as a molecular funnel is formed from calix[6]arene 1 and [CuI(NCCH3)4]PF6 [Eq. (a)]. An exchange of the well-protected acetonitrile ligand for other nitriles RCN is only possible with small R groups. The protection of the copper ions precludes oxidative dimerization; thus, the complexes mimic the mononuclear site of copper enzymes.